Published in Clin Exp Immunol on January 01, 1993
Candida albicans response regulator gene SSK1 regulates a subset of genes whose functions are associated with cell wall biosynthesis and adaptation to oxidative stress. Eukaryot Cell (2003) 1.53
Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol Rev (1995) 1.32
Histone acetyltransferase Rtt109 is required for Candida albicans pathogenesis. Proc Natl Acad Sci U S A (2010) 1.12
Gamma interferon is not essential in host defense against disseminated candidiasis in mice. Infect Immun (1997) 0.96
Candida albicans and Candida krusei differentially induce human blood mononuclear cell interleukin-12 and gamma interferon production. Infect Immun (2000) 0.89
Combined effect of fluconazole and thymosin alpha 1 on systemic candidiasis in mice immunosuppressed by morphine treatments. Clin Exp Immunol (1994) 0.75
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science (1988) 11.05
Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med (1966) 7.30
Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol (1985) 7.20
Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med (1984) 6.11
The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labelling of a component polypeptide of the oxidase. Biochem J (1986) 4.35
The O2- -forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function. Biochim Biophys Acta (1986) 3.32
Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J Immunol (1986) 2.37
Immune interferon enhances functional properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor. J Immunol (1987) 2.24
Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes. Infect Immun (1977) 2.23
Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J Clin Invest (1988) 2.18
Phagocytosis mediated by three distinct Fc gamma receptor classes on human leukocytes. J Exp Med (1990) 1.89
Early effects of HIV on CD4 lymphocytes in vivo. J Immunol (1987) 1.87
Assay of H2O2 production by macrophages and neutrophils with homovanillic acid and horse-radish peroxidase. J Immunol Methods (1983) 1.85
Macrophage phagocytosis: use of fluorescence microscopy to distinguish between extracellular and intracellular bacteria. J Immunol Methods (1991) 1.83
Neutrophil activation by recombinant cytokines. Rev Infect Dis (1989) 1.63
Kinetics of intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Eur J Immunol (1980) 1.55
In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes. J Immunol (1987) 1.51
Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-gamma and glucocorticoids. J Immunol (1988) 1.49
The growing problem of mycoses in patients infected with the human immunodeficiency virus. Rev Infect Dis (1991) 1.47
Gamma interferon is able to enhance the oxidative metabolism of human neutrophils. Biochem Biophys Res Commun (1986) 1.46
High incidence of fungus infections in renal transplantation patients treated with antilymphocyte and conventional immunosuppression. Transplant Proc (1973) 1.31
Mechanism for candidacidal activity in macrophages activated by recombinant gamma interferon. Infect Immun (1991) 1.29
Interferon-gamma activates human neutrophil oxygen metabolism and exocytosis. Immunology (1988) 1.27
Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infection. Eur J Clin Microbiol Infect Dis (1988) 1.25
Interferon-gamma-activated human granulocytes kill ingested Mycobacterium fortuitum more efficiently than normal granulocytes. Eur J Immunol (1990) 1.24
Phagocytosis and intracellular killing of pathogenic yeasts by human monocytes and neutrophils. Infect Immun (1979) 1.21
Disparate effects of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro. J Clin Invest (1991) 1.16
Activation of murine polymorphonuclear neutrophils for fungicidal activity by recombinant gamma interferon. J Leukoc Biol (1987) 1.13
In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon. Infect Immun (1989) 1.07
The use of diphenylene iodonium, an inhibitor of NADPH oxidase, to investigate the antimicrobial action of human monocyte derived macrophages. J Immunol Methods (1990) 1.03
The role of BCG/PPD-activated macrophages in resistance against systemic candidiasis in mice. Scand J Immunol (1992) 0.99
Host factors in defense against fungal infections. Am J Med (1984) 0.88
Immunological aspects of fungal pathogenesis. Eur J Clin Microbiol Infect Dis (1990) 0.85
The origin and kinetics of mononuclear phagocytes. J Exp Med (1968) 14.96
Morphology and peroxidase cytochemistry of mouse promonocytes, monocytes, and macrophages. J Exp Med (1970) 4.26
The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull World Health Organ (1972) 4.25
The effect of glucocorticosteroids on the kinetics of mononuclear phagocytes. J Exp Med (1970) 4.09
Origin, Kinetics, and characteristics of pulmonary macrophages in the normal steady state. J Exp Med (1979) 3.57
Identification and characterization of the monoblast in mononuclear phagocyte colonies grown in vitro. J Exp Med (1975) 3.53
Nitric oxide: a predictor of morbidity in postoperative patients? Lancet (1994) 3.26
Water-related nosocomial pneumonia caused by Legionella pneumophila serogroups 1 and 10. J Infect Dis (1985) 3.16
The kinetics of promonocytes and monocytes in the bone marrow. J Exp Med (1970) 3.12
Origin and kinetics of monocytes and macrophages. Semin Hematol (1970) 2.92
The formation of immunoglobulins by human tissues in vitro. I. The methods and their specificity. Immunology (1966) 2.83
Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax (1995) 2.54
The immunological development of the human fetus. J Exp Med (1965) 2.44
Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes. J Clin Invest (1979) 2.42
The formation of immunoglobulins by human tissues in vitro. IV. Circulating lymphocytes in normal and pathological conditions. Immunology (1966) 2.40
The origin, kinetics, and characteristics of the Kupffer cells in the normal steady state. J Exp Med (1978) 2.29
Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes. Infect Immun (1977) 2.23
The effect of glucocorticosteroids on the proliferation and kinetics of promonocytes and monocytes of the bone marrow. J Exp Med (1973) 2.01
Inability of recombinant interferon-gamma to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium. J Immunol (1987) 1.92
Characteristics of human mononuclear phagocytes. Blood (1979) 1.88
Mechanisms of host defense against infection with Streptococcus pneumoniae. Clin Infect Dis (1992) 1.86
Quantitative studies on the dispersal of skin bacteria into the air. J Med Microbiol (1976) 1.85
Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet (1984) 1.79
Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Infect Immun (1981) 1.74
Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes. Immunology (1979) 1.73
High levels of interleukin 10 and tumor necrosis factor alpha in cerebrospinal fluid during the onset of bacterial meningitis. Clin Infect Dis (1995) 1.70
Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice. Antimicrob Agents Chemother (1989) 1.66
In vitro synthesis of lysozyme by human and mouse tissues and leucocytes. Immunology (1975) 1.64
Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS (1994) 1.61
In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes. J Exp Med (1982) 1.56
Kinetics of intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Eur J Immunol (1980) 1.55
Origin and turnover of monocytes and macrophages. Curr Top Pathol (1989) 1.54
The formation of immunoglobulins by human tissues in vitro. 3. Spleen, lymph nodes, bone marrow and thymus. Immunology (1966) 1.53
Antimicrobial proteins of murine macrophages. Infect Immun (1993) 1.50
In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man. Immunology (1975) 1.50
In vitro synthesis of immunoglobulins, secretory component and complement in normal and pathological skin and the adjacent mucous membranes. Clin Exp Immunol (1973) 1.50
Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. J Infect Dis (1981) 1.48
CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells. J Immunol (1991) 1.45
Cytokines and the host defense against Listeria monocytogenes and Salmonella typhimurium. Biotherapy (1994) 1.42
Macrophage activity and clinical immunology. Origin and kinetics of mononuclear phagocytes. Ann N Y Acad Sci (1976) 1.41
Effect of warfarin on the induction and course of experimental endocarditis. Infect Immun (1976) 1.40
[Bacterial meningitis; pathogenesis and current possibilities of additional therapy]. Ned Tijdschr Geneeskd (1992) 1.40
Monocyte adherence to human vascular endothelium. J Leukoc Biol (1993) 1.38
[Immune response following preventive intracutaneous rabies vaccination]. Ned Tijdschr Geneeskd (1991) 1.38
Exclusive occurrence of K chains in isolated cold haemagglutinins. Scand J Haematol (1965) 1.38
Ubiquicidin, a novel murine microbicidal protein present in the cytosolic fraction of macrophages. J Leukoc Biol (1999) 1.35
Current view on the mononuclear phagocyte system. Immunobiology (1982) 1.35
Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1. Infect Immun (1990) 1.32
Divergent changes in antimicrobial activity after immunologic activation of mouse peritoneal macrophages. J Immunol (1987) 1.31
Infection of human vascular endothelial cells with Staphylococcus aureus induces hyperadhesiveness for human monocytes and granulocytes. J Immunol (1997) 1.31
Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice. J Infect Dis (1993) 1.29
Dual origin of mouse spleen macrophages. J Exp Med (1984) 1.28
Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract. Infect Immun (1999) 1.27
Kinetics of phagocytosis and intracellular killing of Staphylococcus aureus and Escherichia coli by human monocytes. Scand J Immunol (1981) 1.27
Virulence factors determine attachment and ingestion of nonopsonized and opsonized Bordetella pertussis by human monocytes. Infect Immun (1994) 1.27
Endogenous tumor necrosis factor alpha is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant gamma interferon-treated mice. Infect Immun (1992) 1.25
Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infection. Eur J Clin Microbiol Infect Dis (1988) 1.25
Culture of mononuclear phagocytes on a teflon surface to prevent adherence. J Exp Med (1978) 1.25
The use of lysostaphin in in vitro assays of phagocyte function: adherence to and penetration into granulocytes. Scand J Immunol (1981) 1.25
Properties of a factor increasing monocytopoiesis (FIM) occurring in serum during the early phase of an inflammatory reaction. Blood (1977) 1.24
The formation of immunoglobulins by human tissues in vitro. II. Quantitative studies. Immunology (1966) 1.23
Suspension cultures of mononuclear phagocytes in the teflon culture bag. Cell Immunol (1979) 1.23
Proliferative characteristics of monoblasts grown in vitro. J Exp Med (1975) 1.22
Effect of thioglycolate on phagocytic and microbicidal activities of peritoneal macrophages. Infect Immun (1984) 1.22
Role of granulocytes in experimental Streptococcus sanguis endocarditis. Infect Immun (1982) 1.22
Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. Vaccine (2000) 1.22
Quantitative immunocytochemical characterization of mononuclear phagocytes. II. Monocytes and tissue macrophages. Immunology (1987) 1.21
Role of Yops in inhibition of phagocytosis and killing of opsonized Yersinia enterocolitica by human granulocytes. Infect Immun (1995) 1.19
Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect Immun (1996) 1.19
A quantitative evaluation of pulmonary macrophage kinetics. Cell Tissue Kinet (1983) 1.19
Origin and kinetics of pulmonary macrophages during an inflammatory reaction induced by intravenous administration of heat-killed bacillus Calmette-Guérin. J Exp Med (1981) 1.19
Ultrastructure of mononuclear phagocytes developing in liquid bone marrow cultures. A study on peroxidatic activity. J Exp Med (1979) 1.17
Role of granulocytes and monocytes in experimental Staphylococcus epidermidis endocarditis. Infect Immun (1983) 1.16
The formation in vitro of paraproteins in multiple myeloma and Waldenström's macroglobulinaemia. Br J Haematol (1966) 1.15
IgM-IgG cryoglobulinaemia with IgM paraprotein component. Clin Exp Immunol (1968) 1.15
Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study. J Infect Dis (1983) 1.13
Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults. Vaccine (2000) 1.13
Method to prove investigation of particles by macrophages with light microscopy. Scand J Immunol (1980) 1.12
Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus. Clin Infect Dis (1995) 1.11
Humoral regulation of monocytopoiesis during the early phase of an inflammatory reaction caused by particulate substances. Blood (1977) 1.10
Origin and kinetics of Kupffer cells during an acute inflammatory response. Immunology (1979) 1.10
Clinical infections and nonsurgical treatment of parapharyngeal space infections complicating throat infection. Rev Infect Dis (1990) 1.09
Activation of mouse peritoneal macrophages during infection with Salmonella typhimurium does not result in enhanced intracellular killing. J Immunol (1990) 1.09
A serum facted by newborn calf serum. Cell Tissue Kinet (1976) 1.09
Modulation of the intestinal flora of mice by parenteral treatment with broad-spectrum cephalosporins. Antimicrob Agents Chemother (1991) 1.09
Stimulation of the intracellular killing of Staphylococcus aureus by monocytes: regulation by immunoglobulin G and complement components C3/C3b and B/Bb. J Immunol (1982) 1.08
Scleromyxoedema (lichen myxoedematosus) associated with a paraprotein, IgG 1 of type kappa. Br J Dermatol (1973) 1.07
Pneumococcal polysaccharide vaccines: indications, efficacy and recommendations. Eur J Clin Microbiol Infect Dis (1991) 1.07
Differences in the response of inbred mouse strains to the factor increasing monocytopoiesis. J Exp Med (1984) 1.07
Comparative study of the effects of four cephalosporins against Escherichia coli in vitro and in vivo. Antimicrob Agents Chemother (1990) 1.06
Correlation between opsonic activity for various microorganisms and composition of gammaglobulin preparations for intravenous use. J Infect Dis (1984) 1.06
Binding of FimD on Bordetella pertussis to very late antigen-5 on monocytes activates complement receptor type 3 via protein tyrosine kinases. J Immunol (1995) 1.05
Heat shock protein 65 induces CD62e, CD106, and CD54 on cultured human endothelial cells and increases their adhesiveness for monocytes and granulocytes. J Immunol (1996) 1.05
Differences in initial rate of intracellular killing of Salmonella typhimurium by resident peritoneal macrophages from various mouse strains. J Immunol (1985) 1.04
Role of YadA in resistance to killing of Yersinia enterocolitica by antimicrobial polypeptides of human granulocytes. Infect Immun (1996) 1.04
Characterization of monocyte adherence to human macrovascular and microvascular endothelial cells. J Immunol (1990) 1.04
Effect of irradiation, cyclophosphamide, and etoposide (VP-16) on number of peripheral blood and peritoneal leukocytes in mice under normal conditions and during acute inflammatory reaction. Inflammation (1989) 1.04
Quantitative effect of granulocytes on antibiotic treatment of experimental staphylococcal infection. Antimicrob Agents Chemother (1987) 1.03
Characteristics and functional capacities of human cord blood granulocytes and monocytes. Pediatr Res (1984) 1.02
Binding of surfactant protein A to C1q receptors mediates phagocytosis of Staphylococcus aureus by monocytes. Am J Physiol (1994) 1.02